Catalyst
Slingshot members are tracking this event:
Phase 2 data of Nelotanserin in Visual Hallucinations Subjects with Lewy Body Dementia
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
AXON |
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 13, 2017
Occurred Source:
http://www.prnewswire.com/news-releases/axovant-sciences-announces-preliminary-results-from-interim-analysis-of-phase-2-study-testing-investigational-drug-nelotanserin-in-lewy-body-dementia-patients-300406008.html
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Nelotanserin, Visual Hallucinations, Lewy Body Dementia